Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

NHS

NICE wants patients with suspected sepsis to be treated within an hour

Patients with suspected sepsis must be assessed and treated within one hour by hospital staff if they are deemed to be at high risk of severe illness or death, the National Institute for Health and Care Excellence (NICE), the health technology assessment body, has said. 

The announcement, made in a new draft quality standard[1], draws out recommendations from NICE’s 2016 guideline on the management of sepsis[2], which widens the criteria for suspecting sepsis. 

The quality standard says health professionals in any setting, such as GPs, paramedics and A&E staff, should assess people with suspected sepsis, using a specific set of observations, to determine whether there is a high risk that their condition could be life threatening. 

This includes recording vital signs, such as temperature, heart rate, respiratory rate, level of consciousness, oxygen saturation, and blood pressure, as well as checking urination rate, rashes and skin discolouration. 

In hospital, anyone identified as having at least one criterion suggesting that they are at high risk should be reviewed immediately by a senior clinician, and receive antibiotics within one hour, as well as intravenous fluids if their lactate levels are above 2mmol/litre. 

Systems should be in place to enable antibiotics to be given to high-risk patients in GP practices or ambulances in situations where it will take more than one hour to transfer them to hospital. 

Gillian Leng, deputy chief executive at NICE, says: “Severe symptoms can develop in sepsis very quickly. If high-risk patients are not identified and treated promptly, people can be left with debilitating problems. In the worst cases, they may die.”

She adds: “We know from recent case reviews that there are inconsistencies in how people’s symptoms are assessed in different settings. More can be done to provide rapid treatment.”

The 2015 report by the National Confidential Enquiry into Patient Outcome and Death says that 40% of people admitted to A&E with sepsis did not have a timely review by a senior clinician, and that there were avoidable delays in administering antibiotics in almost 29% of cases and inconsistent early use of IV fluid[3].

The draft quality standard is now out for public consultation until 7 April 2017.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202433

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Non-prescription Medicines

    Non-prescription Medicines

    Reviews over-the-counter medicines, arranged by the conditions they are licensed to treat. Includes product recommendations.

    £37.00Buy now
  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £21.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £42.00Buy now
  • Application and Review of Pediatric Pharmacotherapy

    Application and Review of Pediatric Pharmacotherapy

    Increase your understanding of pharmacotherapy prescribed to pediatric patients with these realistic case studies.

    £32.00Buy now
  • Integrated Pharmacy Case Studies

    Integrated Pharmacy Case Studies

    Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.

    £42.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £37.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.